- Home
- CRVO vs SPAI Comparison
CRVO vs SPAI Comparison
Compare CRVO & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | SPAI |
|---|---|---|
| Founded | 2001 | 2021 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.1M | 87.0M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | CRVO | SPAI |
|---|---|---|
| Price | $7.33 | $4.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $21.50 | $10.00 |
| AVG Volume (30 Days) | 60.7K | ★ 342.6K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,159,786.00 | $1,266,756.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $627.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $1.47 |
| 52 Week High | $16.94 | $9.16 |
Technical Indicators
Market Signals| Indicator | CRVO | SPAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | 45.05 |
| Support Level | $7.61 | $3.23 |
| Resistance Level | $8.55 | $4.48 |
| Average True Range (ATR) | 0.59 | 0.44 |
| MACD | -0.17 | -0.05 |
| Stochastic Oscillator | 11.71 | 45.85 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About SPAI Safe Pro Group Inc.
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.